Tianyin Pharmaceutical Co., Inc. to Host First Quarter Fiscal 2010 Earnings Conference Call and Webcast on Friday, November 13th
November 09 2009 - 7:00AM
PR Newswire (US)
CHENGDU, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and
supplier of modernized traditional Chinese medicine ('TCM') based
in Chengdu, China, today announced that management will hold a
conference call to discuss its fiscal 2010 first quarter results at
10:30 a.m. ET on Friday, November 13, 2009. Financial results will
be released prior to the market open on that day. A PowerPoint
presentation which provides further details on the quarter and the
recently announced Sichuan Jiangchuan Pharmaceutical Co. Ltd. joint
venture will accompany management's discussion and can be accessed
via the webcast link. Call Access Information: (877) 941-2321 from
within the United States (480) 629-9714 if calling internationally
Conference ID is 4182573 A replay will be available through
November 21, 2009 and can be accessed by dialing (800) 406-7325
(U.S.), (303) 590-3030 (Int'l), Pin Code 4182573. Webcast Access
Information Access Link:
http://www.talkpoint.com/viewer/starthere.asp?pres=128645 You will
need to have the Windows Media Player on your desktop. For a free
download:
http://www.microsoft.com/windows/windowsmedia/en/download/default.asp
. About Tianyin Pharmaceuticals Tianyin is a manufacturer and
supplier of modernized traditional Chinese medicine in China. It
was established in 1994 and acquired by the current management team
in August 2003. It has a comprehensive product portfolio of 39
products, 22 of which are listed in the highly selective National
Medicine Catalog of the National Medical Insurance program. Tianyin
owns and operates three GMP manufacturing facilities and an R&D
platform supported by leading Chinese academic institutions. The
company has a pipeline of 17 pharmaceutical products pending
approval. Tianyin has an extensive nationwide distribution network
throughout China with a sales force of 720 salespeople. Tianyin is
headquartered in Chengdu, Sichuan Province with three manufacturing
facilities and a total of 1,365 employees. For more information
about Tianyin, please visit http://www.tianyinpharma.com/ . Safe
Harbor Statement The Statements which are not historical facts
contained in this press release are forward-looking statements that
involve certain risks and uncertainties including but not limited
to risks associated with the uncertainty of future financial
results, additional financing requirements, development of new
products, government approval processes, the impact of competitive
products or pricing, technological changes, the effect of economic
conditions and other uncertainties detailed in the Company's
filings with the Securities and Exchange Commission. For more
information, please contact: For the Company: Allen Tang, Ph.D.,
MBA, Assistant to the CEO Tel: +86-158-2122-5642 Email: Investors:
Mr. Matthew Hayden, HC International Tel: +1-561-245-5155 Email:
Web: http://www.hcinternational.net/ DATASOURCE: Tianyin
Pharmaceutical, Co., Inc. CONTACT: Allen Tang, Ph.D., MBA,
Assistant to the CEO of TPI, +86-158- 2122-5642, or ; or Mr.
Matthew Hayden of HC International, +1-561-245-5155, or , for TPI
Web Site: Tianyin Pharmaceutical, Co., Inc.
Copyright